ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 674259 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 674259; 2) Community: the network communities that were significantly associated with the response to NSC 674259; 3) Molecule: the relationships between components within communities and NSC 674259; 4) MDR: the compounds that were significantly associated with the NSC 674259.

NSC Compound Enrichment Correlation
NSC 718781 Erlotinib hydrochloride 0.0348993771550531 -0.1323306
NSC 726217 Combretastatin A4-analogue 0.0348993771550531 0.30188093
NSC 728078 2-carboxy-(2'-furyl)-7-chloro-3-trifluoromethylquinoxaline 1,4-dioxide 0.0348993771550531 0.30424451
NSC 733476 Null 0.0348993771550531 0.27912044
NSC 734288 6-(3-Azidopropyl)-5,6-dihydro-7,8-dimethoxy-3-nitro-5,11-dio xo-11H-indeno[1,2-c]isoquinoline 0.0348993771550531 0.42649087
NSC 751605 (E)-N-[4-(1-benzoylpiperidine-4-yl)butyl]-3-(pyridin-3-yl)acrylamide 0.0348993771550531 0.28459774
NSC 755880 Mitomycin (USAN) 0.0348993771550531 0.1050764
NSC 100046 Elephantopin 0.0350615470435428 -0.060068428
NSC 13300 Null 0.0350615470435428 0.021135586
NSC 254681 5(8H)-Naphthacenone, 8-acetyl-10-[(3-amino-2,3,6-trideoxy- .alpha.-L-lyxo-hexopyranosyl)oxy]-7,9,10,12-tetrahydro-6,8,~ 11-trihydroxy-12-imino-1-methoxy-, monohydrochloride, (8S-cis)- (9CI) 0.0350615470435428 0.36135061
Total:42  Current:26    [First] [Prev] [Next] [Last]